Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2DJerry R. Mendell, K. Reed Clark, Barry J. Byrne et al.|Annals of Neurology|2010Cited by 243
Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteinsJerry R. Mendell, K. Reed Clark, Louise R. Rodino‐Klapac et al.|Annals of Neurology|2009Cited by 214
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M. Birch, Joe N. Kornegay, Michael W. Lawlor et al.|Science Translational Medicine|2023Cited by 68
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophyMichael J. Struharik, Xiaoqing Pan, Amanda K. Bettis et al.|UNC Libraries|2024Cited by 0